RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Quintiles
Transnational Corp. today announced the expansion and consolidation of its
Global Central Laboratories and Clinical Development Services (CDS) units
in Beijing to accommodate their growing business in China.
The new consolidated Quintiles China facility, with more than 17,000
square feet of space, is located at Sun Dong Ann Plaza in Beijing, about
one block from the previous lab site in the Peking Union Medical College
Hospital (PUMCH). The new facility expands the lab space by 2,600 square
feet. The lab has 13 employees and continues to add staff. CDS occupies
10,000 square feet of the combined office area, a major expansion over its
old facility of under 3,000 square feet. The CDS staff strength continues
to grow in Beijing and is expected to reach more than 60 people over the
next 12 months.
"Quintiles' business is growing at a significant rate, and our larger
facility will allow us to efficiently accommodate both the growth and our
expanding test menu, which have moved well beyond basic safety testing to
include specialized chemistry, PCR testing and complex flow cytometry,"
said Tom Wollman, Senior Vice President, Global Central Laboratories.
"We would like to thank the Peking Union Medical College Hospital for
all that it has done to help Quintiles establish and expand our Central
Laboratory in China," Wollman said. "PUMCH is one of the premier tertiary
centers in Beijing, and we will continue to foster our close working
relationship with key laboratory and scientific staff."
Lai Lee Tan, head of Clinical Operations and General Manager in China,
said the consolidation of CDS and Central Lab operations in a single
facility will improve coordination and efficiency for Quintiles' customers.
"Our clinical development business is poised for rapid acceleration in
China, and bringing our CDS and Global Labs businesses together will help
our customers. The globalization of clinical research is continuing to
increase, and China is just beginning to see the rapid growth we have
experienced in India, Australia and throughout Asia Pacific."
Quintiles' China central lab is certified by the College of American
Pathologists (CAP) and the National Glycohemoglobin Standardization Program
(NGSP).
About Quintiles Global Central Laboratories
Quintiles Laboratories owns a network of clinically harmonized
facilities in the U.S., Europe, South Africa, China, India and Singapore,
and has tightly controlled sub-contractor laboratories in Argentina and
Brazil managed by Quintiles employees located in each of the facilities.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With more than
19,000 employees and offices in more than 50 countries, it is focused on
providing customer-centric solutions that are the gold standard of the
industry. For more information, please visit the company's Web site at
http://www.quintiles.com .
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.quintiles.com
CONTACT:
Media Relations, Dick Jones, +1-919-998-2091,
media.info@quintiles.com, or Investor Relations, Greg Connors,
+1-919-998-2000, invest@quintiles.com, both of Quintiles
Transnational Corp.
|
